Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and Wales

Current UK vaccination policy is to offer future COVID-19 booster doses to individuals at high risk of serious illness from COVID-19, but it is still uncertain which groups of the population could benefit most. In response to an urgent request from the UK Joint Committee on Vaccination and Immunisat...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:The Lancet (British edition) Ročník 400; číslo 10360; s. 1305 - 1320
Hlavní autoři: Agrawal, Utkarsh, Bedston, Stuart, McCowan, Colin, Oke, Jason, Patterson, Lynsey, Robertson, Chris, Akbari, Ashley, Azcoaga-Lorenzo, Amaya, Bradley, Declan T, Fagbamigbe, Adeniyi Francis, Grange, Zoe, Hall, Elliott C R, Joy, Mark, Katikireddi, Srinivasa Vittal, Kerr, Steven, Ritchie, Lewis, Murphy, Siobhán, Owen, Rhiannon K, Rudan, Igor, Shah, Syed Ahmar, Simpson, Colin R, Torabi, Fatemeh, Tsang, Ruby S M, de Lusignan, Simon, Lyons, Ronan A, O'Reilly, Dermot, Sheikh, Aziz
Médium: Journal Article
Jazyk:angličtina
Vydáno: England Elsevier Ltd 15.10.2022
Elsevier Limited
The Author(s). Published by Elsevier Ltd
Témata:
ISSN:0140-6736, 1474-547X, 1474-547X
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Buďte první, kdo okomentuje tento záznam!
Nejprve se musíte přihlásit.